INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $105,000 | -68.8% | 144,414 | +86.7% | 0.00% | -75.0% |
Q2 2019 | $336,000 | -17.8% | 77,348 | +38.5% | 0.01% | -33.3% |
Q1 2019 | $409,000 | -43.7% | 55,838 | -42.1% | 0.01% | -60.0% |
Q4 2018 | $727,000 | +19.4% | 96,370 | -10.6% | 0.03% | +66.7% |
Q3 2018 | $609,000 | – | 107,761 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,337,191 | $7,555,000 | 4.21% |
DAFNA Capital Management LLC | 537,000 | $3,034,000 | 1.25% |
MEITAV INVESTMENT HOUSE LTD | 2,867,047 | $15,073,000 | 0.74% |
SECTORAL ASSET MANAGEMENT INC | 1,176,775 | $6,649,000 | 0.71% |
Avoro Capital Advisors LLC | 2,570,705 | $14,524,000 | 0.67% |
KNOTT DAVID M | 283,473 | $1,602,000 | 0.52% |
CAXTON CORP | 64,396 | $364,000 | 0.34% |
Harel Insurance Investments & Financial Services Ltd. | 658,835 | $3,722,000 | 0.18% |
Migdal Insurance & Financial Holdings Ltd. | 589,996 | $3,333,000 | 0.07% |
683 Capital Management, LLC | 150,000 | $848,000 | 0.06% |